Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components (Details) - Schedule of accrued liabilities

v3.22.1
Balance Sheet Components (Details) - Schedule of accrued liabilities - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Schedule of accrued liabilities [Abstract]    
Accrued labor costs $ 1,015 $ 691
Accrued drug development costs 496 369
Other 147 152
Total $ 1,658 $ 1,212